module 4 pregnancy, childbirth, and postpartum at risk

105
MODULE 4 PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

Upload: kizzy

Post on 05-Jan-2016

28 views

Category:

Documents


1 download

DESCRIPTION

MODULE 4 PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK. PREGNANCY AT RISK PREGESTATIONAL GESTATIONAL CHILDBIRTH AT RISK PRE—LABOR COMPLICATIONS LABOR—RELATED COMPLICATIONS POSTPARTUM AT RISK. MODULE 4 PART 1A PREGESTATIONAL RISKS SUBSTANCE ABUSE. SUBSTANCE ABUSE DURING PREGNANCY. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

MODULE 4 PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

Page 2: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

PREGNANCY AT RISK PREGESTATIONAL

GESTATIONAL

CHILDBIRTH AT RISK PRE—LABOR COMPLICATIONS

LABOR—RELATED COMPLICATIONS

POSTPARTUM AT RISK

Page 3: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

MODULE 4 PART 1APREGESTATIONAL RISKS

SUBSTANCE ABUSE

Page 4: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

SUBSTANCE ABUSE DURING PREGNANCY

• ALCOHOL

– CNS DEPRESSANT

– INCIDENCE OF ABUSE HIGHEST IN MOTHERS 20-40 YEARS OF AGE

– PREGNANT WOMEN SHOULD AVOID ALCOHOL COMPLETELY DURING PREGNANCY—WHY?

– ADVERSE MATERNAL EFFECTS

– ADVERSE FETUS/NEONATAL EFFECTS

Page 5: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

Fetal Alcohol Syndrome

Retrieved from: http://www.aafp.org/afp/2005/0715/p279.html

Page 6: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

SUBSTANCE ABUSE DURING PREGNANCY

• COCAINE AND CRACK– PREVENTS REUPTAKE OF DOPAMINE,

NOREPINEPHRINE—LEADS TO VASOCONSTRICITION, TACHYCARDIA, HYPERTENSION

– ADVERSE MATERNAL EFFECTS– ADVERSE FETAL/NEONATAL EFFECTS

Page 7: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

SUBSTANCE ABUSE DURING PREGNANCY

• MARIJUANA– NO STRONG RESEARCH INDICATING

TERATOGENIC EFFECTS– SOCIAL FACTORS

• HEROIN/METHADONE– ADVERSE MATERNAL EFFECTS– ADVERSE FETAL/NEONATAL EFFECTS

Page 8: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

SUBSTANCE ABUSE DURING PREGNANCY

• BARBITURATES

• STIMULANTS

• CAFFEINE

• NICOTINE

• PSYCHOTROPICS

• METH

Page 9: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK
Page 10: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

MODULE 4 PART 1BPREGESTATIONAL RISKS:

DIABETES

Page 11: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

DIABETES MELLITUS IN PREGNANCY

• PATHOPHYSIOLOGY– INSULIN PRODUCTION DECREASE BY

PANCREAS– WITHOUT ADEQUATE INSULIN, GLUCOSE

DOES NOT ENTER CELLS, WHICH BECOME ENERGY DEPLETED

– BLOOD GLUCOSE LEVELS INCREASE– CELLS BREAK DOWN PROTEIN AND FAT

STORES FOR ENERGY

Page 12: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

DIABETES MELLITUS IN PREGNANCY

• EARLY PREGNANCY

– ESTROGEN, PROGESTERONE, OTHER HORMONES RISE TO STIMULATE INCREASED INSULIN PRODUCTION AND INCREASED TISSUE RESPONSE TO INSULIN

– STORAGE OF GLYCOGEN IN LIVER PRODUCES ANABOLIC STATE DURING IST HALF OF PREGNANCY

Page 13: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

DIABETES MELLITUS IN PREGNANCY

• 2ND HALF OF PREGNANCY PRESENTS WITH INCREASED RESISTANCE TO INSULIN AND DECREASED GLUSOSE TOLERANCE DUE TO:– SECRETION OF Hpl (INSULIN

ANTAGONIST) PROLACTIN, INCREASED CORTISOL AND GLYCOGEN LEVELS

– RESULTS IN CATABOLIC STATE

• DIABETOGENIC EFFECT

Page 14: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

DIABETES IN PREGNANCY

• CLASSIFICATIONS– ETIOLOGIC

• TYPE I• TYPE II• TYPE III• TYPE IV• BASED ON CAUSE

– WHITE’S• CLASS A-T• DESCRIBES EXTENT OF DISEASE

Page 15: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK
Page 16: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK
Page 17: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

GESTATIONAL DIABETES

• GESTATIONAL DIABETES– WHY DOES THIS OCCUR?

-- WHEN DOES THIS OCCUR?

– WHAT IS THE INCIDENCE OF THIS OCCURING DURING PRGNANCY?

– HOW IS IT DIAGNOSED?

Page 18: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

COMPARISON OF DIABETES MELLITUS AND GESTATIONAL DIABETES

Page 19: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

DIABETES MELLITUS IN PREGNANCY

• INTRAPARTAL MANAGEMENT– WHEN TO DELIVER

– LABOR MANAGEMENT, INSULIN REQUIREMENTS

• POSTPARTAL MANAGEMENT– INSULIN REQUIREMENTS

– BREAST FEEDING

Page 20: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

DIABETES IN PREGNANCY

• CHALLENGES, INFLUENCES

• MATERNAL RISKS

• FETAL, NEWBORN RISKS

Page 21: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

DIABETES MELLITUS IN PREGNANCY

• CLINICAL TREATMENT– GTT CRITERIA

• LAB ASSESSMENT

• ANTEPARTAL MANAGEMENT– DIET– GLUCOSE MONITORING– INSULIN REQUIREMENTS– FETAL EVALUATION

Page 22: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

MODULE 4 PART 1CPREGESTATIONAL RISKS

INFECTIONS

Page 23: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

HIV IN PREGNANCY

• RISKS TO MOTHER

• RISKS TO FETUS/NEONATE

• ANTEPARTUM, INTRAPARTUM, POSTPARTUM TREATMENT & CARE

Page 24: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

TORCH• TOXOPLAMOSIS

• OTHER– GBS

• RUBELLA

• CYTOMEGALIVIRUS

• HERPES

Page 25: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK
Page 26: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

TORCH

• MATERNAL RISKS

• FETAL RISKS

• ANTEPARTUM, INTRAPARTUM, POSTPARTUM TREATMENT AND CARE

Page 27: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

GROUP B STREPTOCOCCUS

• INCIDENCE

• TESTING

• TREATMENT

• NURSING INTERVENTIONS

Page 28: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

GESTATIONAL PREGNANCY RISKS• BLEEDING DISORDERS

• HYPERTENSIVE DISORDER

• Rh ALLOIMMUNIZATION

• ABO INCOMPATIBILITY

• DOMESTIC VIOLENCE

• SURGERY, TRAUMA

Page 29: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

MODULE 4 PART 2AGESTATIONAL ONSET

COMPLICATIONS:BLEEDING DISORDERS

Page 30: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

BLEEDING DISORDERS

• ECTOPIC PREGNANCY– TREATMENT, RISKS

• GESTATIONAL TROPHOBLASTIC DISEASE

– HYDATIFORM MOLE

– CHORIOADENOMA DESTRUENS

– CHORIOCARCINOMA

– TREATMENT, RISKS

Page 31: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK
Page 32: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK
Page 33: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK
Page 34: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

GESTATIONAL RISKS

• INCOMPETENT CERVIX– CERCLAGE

• HYPEREMESIS GRAVIDARUM– FLUID & ELECTROLYTE ISSUES– DEHYDRATION– RISKS TO FETUS– NURSING CARE

Page 35: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

Cerclage

Retrieved from: www.drlindagalloway.wordpress.com

Page 36: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

GESTATIONAL RISKS

• PREMATURE RUPTURE OF MEMBRANES

– PROM

– PPROM

– NST, BPP

RISKS

NURSING CARE

Page 37: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

Positive Fern Test

Retrieved from: commons.wikimedia.org

Page 38: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

MODULE 4 PART 2B GESTATIONAL

COMPLICATIONS AND RISKS:PREGNANCY REDUCED

HYPERTENSION

Page 39: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

PREGNANCY INDUCED HYPERTENSION--PIH

– PREECLAMPSIA/ECLAMPSIA

– CHRONIC HYPERTENSION

– CHRONIC HYPERTENSION WITH SUPERIMPOSED PREECLAMPSIA OR ECLAMPSIA

– TRANSIENT HYPERTENSION

Page 40: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

PREECLAMPSIA

• DISEASE OF THEORIES

• MOST COMMON HYPERTENSIVE DISORDER IN PREGNANCY

• PATHOPHYSIOLOGY– CAUSE UNKNOWN– 5-7% OF ALL PREGNANCIES– GENERALIZED VASOSPASM, DECREASE

IN CIRCULATING BLOOD VOLUME

Page 41: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

Preeclampsia

Page 42: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

PREECLAMPSIA• PRENATAL FACTORS INCREASING RISK OF

PIH– PRIMIGRAVIDA– ESSENTIAL HYPERTENSION– AGE EXTREMES (UNDER 17 OR OVER 35

YEARS OLD)– UNDERWEIGHT OR OVERWEIGHT– FAMILY HISTORY OF HYPERTENSION– DIAGNOSIS OF PIH IN PREVIOUS

PREGNANCY– DIABETES MELLITUS

Page 43: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

PREECLAMPSIA

• CHARACTERIZED BY:– DEVELOPMENT OF HYPERTENSION

• 30MM HG INCREASE IN SYSTOLIC AND 15 MM HG DIASTOLIC OVER BASELINE ON AT LEAST 2 OCCASIONS 6 OR MORE HOURS APART

– PROTEINURIA ,HYPERREFLEXIA– EDEMA– MATERNAL RISKS– FETAL/NEONATAL RISKS

Page 44: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

PREECLAMPSIA

• CLINICAL MANAGEMENT/CARE– ANTEPARTAL MANAGEMENT

• MILD PREECLAMPSIA• SEVERE PREECLAMPSIA

– INTRAPARTAL MANAGEMENT– POSTPARTAL MANAGEMENT

• HELLP SYNDROME• ECLAMPSIA

Page 45: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

H E L L P Syndrome

• H – hemolysis- distortion and rupture of RBCs

• E – elevated

• L – liver enzymes- fibrin deposits obstruct blood flow

• L – low

• P – platelet count

Page 46: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK
Page 47: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK
Page 48: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK
Page 49: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

MODULE 4 PART 2CGESTATIONAL RISKS &

COMPLICATIONS: Rh ISOIMMUNIZATION

Page 50: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

Rh SENSITIZATION

• ANTIGEN-ANTIBODY RESPONSE– IF AN Rh-NEGATIVE WOMAN IS EXPOSED

TO Rh POSITIVE BLOOD, EITHER THROUGH TRANSFUSION OR A PRIOR PREGNANCY, SHE PRODUCES IMMUNOGLOBULIN (Ig)G ANTIBODY (ANTIRhD)

– INDIRECT COOMBS TEST– DIRECT COOMBS TEST

Page 51: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

Figure 13–5d Anti-Rh-positive antibodies (triangles) are formed.

Page 52: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

Figure 13–5b Pregnancy with Rh-positive fetus. Some Rh-positive blood enters the mother’s bloodstream.

Page 53: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

Figure 13–5e In subsequent pregnancies with an Rh-positive fetus, Rh-positive red blood cells are attacked by the anti-Rh-positive maternal antibodies, causing hemolysis of the red blood cells in the fetus.

Page 54: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

Rh SENSITIZATION

• RhoGAM– PROVIDES PASSIVE ANTIBODY

PROTECTION AGAINST Rh ANTIGENS

• ERYTHROBLASTOSIS FETALIS

• HYDROPS FETALIS

• KERNICTERUS

Page 55: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

MODULE 4 PART 2CBLEEDING

COMPLICATIONS

Page 56: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

PRE-LABOR COMPLICATIONS

• PREMATURE RUPTURE OF MEMBRANES

• PRETERM LABOR

• BLEEDING

• MULTIPLE GESTATION

• AMNIOTIC FLUID ALTERATIONS

Page 57: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

ABRUPTIO PLACENTAE

• ABRUPTIO PLACENTAE:– PREMATURE SEPARATION OF PLACENTA

FROM UTERINE WALL– THREE TYPES:

• MARGINAL• CENTRAL• COMPLETE

– CLINICAL MANAGEMENT

Page 58: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

Figure 19–11a Abruption placentae. Marginal abruption with external hemorrhage.

Page 59: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

Figure 19–11c Complete separation.

Page 60: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

Figure 19–11b Central abruption with concealed hemorrhage.

Page 61: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

PLACENTA PREVIA

• PLACENTA PREVIA: IMPLANTATION OF PLACENTA IN LOWER UTERINE SEGMENT

• THREE CLASSIFICATIONS:– LOW PLACENTAL IMPLANTATION– PARTIAL PLACENTA PREVIA– TOTAL PLACENTA PREVIA

• CLINICAL MANAGEMENT

Page 62: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

Figure 19–12a Placenta previa. Low placental implantation.

Page 63: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

Figure 19–12c Total placenta previa.

Page 64: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

Figure 19–12b Partial placenta previa.

Page 65: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK
Page 66: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

MODULE 4 PART 2DSURGERY TRAUMA

INFECTIONDOMESTIC VIOLENCE

Page 67: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

SURGERY

TRAUMA FROM AN ACCIDENT

INFECTION AFFECTING THE FETUS

– MATERNAL RISKS

– FETAL RISKS

Page 68: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

DOMESTIC VIOLENCE IN PREGNANCY

• INCIDENCE

• RESEARCH

• STATISITICS

• SIGNS AND SYMPTOMS

Page 69: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

DOMESTIC VIOLENCE IN PREGNANCY

• HOW DO WE ASSESS?

• WHEN DO WE ASSESS?

• WHAT DO WE DO IF THE WOMAN DISCLOSES ABUSE?

• MATERNAL RISKS

• FETAL RISKS

Page 70: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK
Page 71: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK
Page 72: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

MODULE 4 PART 3APRE-LABOR COMPLICATIONS

AMNIOTIC FLUID ALTERATIONS

Page 73: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

OLIGOHYDRAMNIOS

• SEVERELY REDUCED AMOUNT OF AMNIOTIC FLUID

• OCCURS IN:

– POSTMATURITY– IUGR– FETAL RENAL MALFORMATION– SOMETIMES IDIOPATHIC

Page 74: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

OLIGOHYDRAMNIOS

• FETAL RISKS

• CLINICAL MANAGEMENT

• CRITICAL THINKING– WHAT TYPE OF DECELERATION MIGHT

YOU EXPECT TO SEE ON THE FETAL MONITOR OF A WOMAN WITH OLIGOHYDRAMNIOS? WHY?

Page 75: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

HYDRAMNIOS

• HYDRAMNIOS: > 2000ML AMNIOTIC FLUID

• CAUSE UNKNOWN 20% ASSOCIATED WITH CONGENITAL ANOMALIES

• TWO TYPES:– CHRONIC – ACUTE

RISKS

• CLINICAL MANAGEMENT

Page 76: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

True knot

Page 77: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

MODULE 4 PART 3BPRE-LABOR

COMPLICATIONS:PRETERM LABORLABOR RELATED COMPLICATIONS

Page 78: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

PRETERM LABOR

– NONRECURRENT

– SCREENING

– FACTORS CORRELATED WITH PRETERM LABOR

Page 79: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

PRETERM LABOR

• PRETERM RISK FACTORS– LABOR THAT OCCURS BETWEEN 20-38

WEEKS

– PREVELANCE

– RESEARCH

– RECURRENT

Page 80: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

PRETERM LABOR

• TREATMENT/CARE– HOME UTERINE ACTIVITY MONITORING– TOCOLYSIS

• MGSO4• NEPHEDIPINE• PROSTAGLANDIN SYNTHESIS

INHIBITORS• BETAMETHASONE (FETUS)

Page 81: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

LABOR RELATED COMPLICATIONS

• DYSTOCIA

• POSTTERM PREGNANCY

• FETAL MALPOSITION, MALPRESENTATION

• MACROSOMIA

• FETAL DISTRESS

Page 82: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

LABOR RELATED COMPLICATIONS

• HYPERTONIC LABOR

• HYPOTONIC LABOR– LABOR MANAGEMENT– MATERNAL RISKS– FETAL/NEONATAL RISKS

• PRECIPITOUS LABOR– LABOR LESS THAN 3 HOURS

Page 83: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

LABOR RELATED COMPLICATIONS

• PROLAPSED UMBILICAL CORD

• AMNIOTIC FLUID EMBOLISM

• CEPHALOPELVIC DISPROPORTION

• COMPLICATION OF THIRD OR FOURTH STAGE OF LABOR

Page 84: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

Uterine Tachysystole

Page 85: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

LABOR RELATED COMPLICATIONS

• MACROSOMIA– NEWBORN WEIGHT > 4000 GMS– OFTEN SEEN IN:

• DIABETIC MOTHERS• GRAND MULTIPARITY• POSTTERM GESTATION• LARGE PARENTS

– MATERNAL RISKS– FETAL / NEONATAL RISKS

Page 86: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

MODULE 4 PART 3CLABOR RELATED COMPLICATIONS

Page 87: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

POSTTERM PREGNANCY, MALPOSITION

• POSTTERM PREGNANCY– PREGNANCY 42 WEEKS PAST 1ST DAY OF LAST

MENSTRUAL PERIOD– MATERNAL RISKS– FETAL/NEONATAL RISKS

• MALPOSITION– OCCIPUT POSTERIOR– PERSISTENT OCCIPUT POSTERIOR– LABOR MANAGEMENT– MATERNAL RISKS

Page 88: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

PROLAPSED UMBILICAL CORD

• PROLAPSED CORD: WHEN CORD PRECEDES FETAL PRESENTING PART

• DECREASED BLOOD FLOW IN CORD LEADS TO FETAL DISTRESS

• MAY RESULT WITH RUPTURE OF MEMBRANES

• CLINICAL MANAGEMENT

Page 89: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK
Page 90: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

Nurse and Prolapsed cord

Page 91: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

AMNIOTIC FLUID EMBOLISM

• CLINICAL PRESENTATION– CHEST PAIN– DYSPNEA– CYANOSIS– HYPOTENSION– TACHYCARDIA– MASSIVE HEMORRHAGE

• CLINICAL MANAGEMENT

Page 92: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

AMNIOTIC FLUID EMBOLISM

• AMNIOTIC FLUID EMBOLISM: AMNIOTIC FLUID MAY LEAK INTO CHORIONIC PLATE AND MATERNAL CIRCULATORY SYSTEM THROUGH: – TEAR IN AMNION OR CHORION– PLACENTAL SEPARATION– CERVICAL TEAR

Page 93: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

CEPHALOPELVIC DISPROPORTION (CPD)

• FETUS LARGER THAN PELVIC DIAMETERS

• PELVIC MEASUREMENTS

• PROLONGED LABOR

• CLINICAL MANAGEMENT

Page 94: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

MALPRESENTATION

• MALPRESENTATION– BROW– FACE– BREECH– SHOULDER– TRANSVERSE LIE– COMPOUND PRESENTATION

Page 95: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

MULTIPLE GESTATION

• INCREASED INCIDENCE OF MULTIPLE BIRTHS

• INCREASED INCIDENCE OF PRETERM LABOR

• FETAL AND MATERNAL IMPLICATIONS AND CARE

Page 96: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK
Page 97: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK
Page 98: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

FETAL DISTRESS

• FETAL DISTRESS

• CONTIBUTING FACTORS:– CORD COMPRESSION– UTERO-PLACENTAL INSUFFCIENCY– PREEXISTING MATERNAL OR FETAL

DISEASE

• FETAL DISTRESS WARNING SIGNS– MECONIUM STAINED AMNIOTIC FLUID

Page 99: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

FETAL DISTRESS

• OMINOUS FHR PATTERNS– PERSISTENT LATE DECELERATIONS

– PERSISTENT SEVERE VARIABLE DECELERATIONS

– PROLONGED DECELERATIONS

– DECREASED VARIABILITY

Page 100: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK
Page 101: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

FETAL DEATH

• INTRAUTERINE FETAL DEATH

• POSSIBLE CAUSES:

– PREECLAMPSIA

– ABRUPTIO PLACENTAE

– PLACENTA PREVIA

– DIABETES

– CONGENITAL ANOMALIES

– INFECTION

Page 102: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

FETAL DEATH

• ISOIMMUNE DISEASE

• NUCAL CORD

• UNKNOWN CAUSES

• PROLONGED RETENTION OF FETUS MAY LEAD TO:

• DESSEMINATED INTRAVASCULAR COAGULATION (DIC)

Page 103: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK
Page 104: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

COMPLICATIONS OF THE THIRD & FOURTH STAGE OF LABOR

• LACERATIONS– 1ST DEGREE– 2ND DEGREE– 3RD DEGREE– 4TH DEGREE

• SULCUS TEAR

• URETHRAL TEAR

Page 105: MODULE 4  PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

COMPLICATIONS OF THE THIRD AND FOURTH STAGE OF LABOR

• PLACENTA ACCRETA:– ATTACHMENT OF PLACENTA DIRECTLY TO THE

UTERINE WALL WITHOUT INTEVENING DECIDUA BASALIS

• UTERINE RUPTURE• RETAINED PLACENTA

• UTERINE ATONY• HEMMORHAGE